DK292590A - Rifapentin-hydrohalogenider - Google Patents

Rifapentin-hydrohalogenider Download PDF

Info

Publication number
DK292590A
DK292590A DK292590A DK292590A DK292590A DK 292590 A DK292590 A DK 292590A DK 292590 A DK292590 A DK 292590A DK 292590 A DK292590 A DK 292590A DK 292590 A DK292590 A DK 292590A
Authority
DK
Denmark
Prior art keywords
pct
rifapentine
sec
date
hydrohalides
Prior art date
Application number
DK292590A
Other languages
English (en)
Other versions
DK173423B1 (da
DK292590D0 (da
Inventor
Emilio Occelli
Marino Nebuloni
Bruno Cavalleri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK292590A publication Critical patent/DK292590A/da
Publication of DK292590D0 publication Critical patent/DK292590D0/da
Application granted granted Critical
Publication of DK173423B1 publication Critical patent/DK173423B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fats And Perfumes (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK199002925A 1988-07-13 1990-12-10 Rifapentin-hydrohalogenider, fremgangsmåde til fremstilling deraf, farmaceutisk dosisform indeholdende dem samt deres anven DK173423B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8816620 1988-07-13
GB888816620A GB8816620D0 (en) 1988-07-13 1988-07-13 Rifapentine hydrohalides
EP8900694 1989-06-21
PCT/EP1989/000694 WO1990000553A1 (en) 1988-07-13 1989-06-21 Rifapentine hydrohalides

Publications (3)

Publication Number Publication Date
DK292590A true DK292590A (da) 1990-12-10
DK292590D0 DK292590D0 (da) 1990-12-10
DK173423B1 DK173423B1 (da) 2000-10-09

Family

ID=10640347

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199002925A DK173423B1 (da) 1988-07-13 1990-12-10 Rifapentin-hydrohalogenider, fremgangsmåde til fremstilling deraf, farmaceutisk dosisform indeholdende dem samt deres anven

Country Status (19)

Country Link
US (1) US5306715A (da)
EP (1) EP0440642B1 (da)
JP (1) JP2716553B2 (da)
KR (1) KR0135312B1 (da)
CN (1) CN1039421A (da)
AT (1) ATE111101T1 (da)
AU (1) AU632754B2 (da)
CA (1) CA1339215C (da)
DE (1) DE68918107T2 (da)
DK (1) DK173423B1 (da)
ES (1) ES2018374A6 (da)
GB (1) GB8816620D0 (da)
GR (1) GR1002222B (da)
HU (1) HU210716A9 (da)
IE (1) IE65812B1 (da)
IL (1) IL90892A0 (da)
PT (1) PT91132B (da)
WO (1) WO1990000553A1 (da)
ZA (1) ZA894991B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
DE69111607T2 (de) * 1990-06-29 1995-12-21 Lepetit Spa Reine kristalline form von rifapentin.
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
JP4393098B2 (ja) * 2002-06-21 2010-01-06 独立行政法人科学技術振興機構 アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法
CN101219992B (zh) * 2003-02-12 2011-08-31 日产化学工业株式会社 匹伐他汀钙的晶形
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
PT1698630E (pt) * 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
JP2007246514A (ja) * 2006-02-14 2007-09-27 Toyama Chem Co Ltd ピペラシリンナトリウムの新規な結晶
MX2009008124A (es) * 2007-01-31 2009-10-08 Toyama Chemical Co Ltd Cristal nuevo de piperacilina sodica.
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
AU2013212008A1 (en) * 2012-01-25 2014-07-10 Alfa Wassermann S.P.A. Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US20240199642A1 (en) * 2021-04-21 2024-06-20 Interquim S.A. De C.V. Method for obtaining rifapentine with a new crystalline form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (da) * 1964-07-31
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
FR2309556A1 (fr) * 1975-04-29 1976-11-26 Aries Robert Aminoguanidines derivees de la rifamycine
US4876258A (en) * 1987-08-13 1989-10-24 Ciba-Geigy Corporation Biphenylyl compounds
US4916126A (en) * 1987-09-25 1990-04-10 Ciba-Geigy Corporation Diacyl derivatives of 4-(trialkylbenzyl)-piperazinyl compounds

Also Published As

Publication number Publication date
ZA894991B (en) 1990-08-29
DE68918107T2 (de) 1995-01-26
HK1005455A1 (en) 1999-01-08
IE892247L (en) 1990-01-13
ES2018374A6 (es) 1991-04-01
AU632754B2 (en) 1993-01-14
WO1990000553A1 (en) 1990-01-25
KR0135312B1 (ko) 1998-04-23
CN1039421A (zh) 1990-02-07
DE68918107D1 (de) 1994-10-13
DK173423B1 (da) 2000-10-09
PT91132A (pt) 1990-02-08
KR900701798A (ko) 1990-12-04
PT91132B (pt) 1994-12-30
GR1002222B (en) 1996-04-17
HU210716A9 (en) 1995-06-28
DK292590D0 (da) 1990-12-10
JP2716553B2 (ja) 1998-02-18
CA1339215C (en) 1997-08-05
IL90892A0 (en) 1990-02-09
GB8816620D0 (en) 1988-08-17
IE65812B1 (en) 1995-11-15
US5306715A (en) 1994-04-26
EP0440642B1 (en) 1994-09-07
JPH03506025A (ja) 1991-12-26
EP0440642A1 (en) 1991-08-14
ATE111101T1 (de) 1994-09-15
AU3770289A (en) 1990-02-05
GR890100448A (el) 1990-06-27

Similar Documents

Publication Publication Date Title
ES2015286B3 (es) Disposicion para estanqueizar una barra (11.11.11).
NO900619L (no) Substituerte 1,3-okstiolaner.
ATE111101T1 (de) Rifapentin-hydrohalide.
IT1230779B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano.
IT1215759B (it) Unita' di scorrimento ad ampia registrabilita' per macchine operatrici.
FI872210L (fi) Tryckbalk foer saogmaskiner.
IT8519908A0 (it) Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine.
FI910653A0 (fi) Synteettiset reseptorianalogit
ES557075A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
IT1230795B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano da 1,1 dicloro 1,2,2,2 tetrafluoroetano.
DE69316200D1 (de) Feuchtigkeitsspender
FI901213A0 (fi) Substituerade (kinolin-2-ylmetoxi) fenyl-n,n'-sulfonylurinaemnen, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES545622A0 (es) Un procedimiento para preparar bisarilamidas de n,n'-di(1 aminoalquil-2) alquilendiaminas.
NO905244L (no) Fremgangsmaate for fremstilling av des(64,65)-proinsulin.
FR2654968B1 (fr) Machine de rodage par expansion d'alesages.
SE9404438D0 (sv) New process
DE3577559D1 (de) 4h-pyrimido(2,1-a)isochinolin-4-onderivate.
FR2673727B1 (fr) Pince amperemetrique comprenant des moyens d'actionnement perfectionnes.
FR2695458B1 (fr) Chalumeau, notamment d'oxycoupage.
FI906269L (fi) 2,19-metylenoxi- och 2,19-metylentio -tvaerbundna steroider som aromatas- och 19-hydroxylasinhibitorer.
NO159842C (no) Dempeventil for ko en tr aktor.
FI902119A0 (fi) Tetrahydroisokino (2,1-c)(1,3) benzodiazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
EP0630904A4 (en) Novel nicotine derivative.
ES554039A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzoxazepina.
DE69021494D1 (de) 1,1,1-Trifluor-2-Hydroxyverbindungen.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired